One of Australia’s leading gastroenterologists says he believes that the herbal remedy, Iberogast (STW 5) has its place among and is probably even superior to more expensive, mainstream treatments for common gastrointestinal disorders.
Flordis held a mini medical symposium in Cape Town, Durban, Johannesburg and Pretoria, outlining the exceptional quality standards set for Flordis natural products targeting memory, mood and energy. International speakers includes Professor Con Stough, Professor Francesco Scaglione and Dr Andrea Zangara.
The adoption of Bacopa monniera (brahmi) by SFI with the American Botanical Council’s Adopt-An-Herb program will ensure up-to-date clinical information for Bacopa monniera is easily available via HerbMedProTM.
Iberogast® (STW 5) was the subject of a symposium on “Functional GI Disease: Solving the Therapeutic Dilemma” held as part of the European Bridging Meeting in Gastroenterology in Berlin, Germany. Here Iberogast was recognised as the only phytotherapeutical remedy which fulfills the description of a multi-target product.
The European Medicines Agency (EMEA) has granted Premular, specific extract of Vitex agnus-castus (Ze 440) a “well-established use” classification “for the treatment of premenstrual syndrome” based on proof of efficacy and safety.1,2